Page last updated: 2024-08-23

paclitaxel and Leukemia, Megakaryocytic

paclitaxel has been researched along with Leukemia, Megakaryocytic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
deFazio, A; Guminski, AD; Harnett, PR1

Other Studies

1 other study(ies) available for paclitaxel and Leukemia, Megakaryocytic

ArticleYear
Carboplatin and paclitaxel interact antagonistically in a megakaryoblast cell line--a potential mechanism for paclitaxel-mediated sparing of carboplatin-induced thrombocytopenia.
    Cancer chemotherapy and pharmacology, 2001, Volume: 48, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Division; Cell Survival; DNA Adducts; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Antagonism; Drug Interactions; Humans; Leukemia, Megakaryoblastic, Acute; Paclitaxel; Thrombocytopenia; Tumor Cells, Cultured

2001